232. J. Sun, J.K. Guo, X.H. Qi, J.T. Yang, G.L. Wang*, G.M. Zhou, F.H. Meng, Z.Y. Zhong*, Dual-targeted radionuclide therapy with ¹⁶¹Tb instigates anticancer immunity in “cold” murine prostate tumor. Mol. Pharm. 2026, 23, 4311–4321.232.pdf

231. X.L. Tang, J.R. Wang, L. Chen, Y. Zhao, L. Cao, H.L. Sun*, Z.Y. Zhong*, Chemoimmunotherapeutic sealants for postsurgical adjuvant therapy of malignant tumors. J. Control. Release. 2026, 396, 115068.231.pdf

230. X.Y. Dong, H. He*, L. Cao, F.H. Meng, Z.Y. Zhong*, Oral prebiotic polysaccharide hydrogels sustaining colon antibody release alleviate inflammatory bowel disease. Adv. Sci. 2026, e76425.230.pdf

299. M. Sun, R.K. Lv, Y.J. Sha, L.Y. Zhu, J. Cao, Z.Y. Zhong*, F.H. Meng*, Sulfasalazine- and cerium ion-loaded polymersomes with enhanced RONS scavenging and colonic mucosal repair ameliorate experimental colitis. Biomacromolecules. 2026, 27, 4734–4746.299.pdf

298. S.Y. Miao, Y.P. Sun, Y.Y. Qu, L.Y. Zhu, Z.Y. Zhong*, F.H. Meng*, Micellar co-delivery of KRAS-mutant inhibitors and TLR7/8 agonists synergizes targeted therapy and immunotherapy in lung cancer. Acta Biomater. 2026, 212, 624–636.298.pdf

297. J.K. Guo, J.T. Huang, Y. Wang, J. Sun, S. Liu, C. Deng*, J. Lu*, and Z.Y. Zhong*, Absorbable microspheres co-delivering HIF-1α inhibitor augment transarterial chemoembolization by reversing tumor hypoxia and immunosuppression. Acta Biomater. 2026, 214, 498–511.297.pdf

296. S.Q. Zhang, R.N. Ye, T.Y. Shi, C.C. Deng, L.M. Chang, Q.Z. Ren, P.Z. Zhang, C.C. Xu*, and Z.Y. Zhong*, High-payload antibody-oligonucleotide-drug conjugates (AODC) for targeted tumor chemo-immunotherapy. J. Control. Release 2026, 398, 115209.296.pdf

295. C.M. Li, Z.Z. Zhai, L. Chen, L. Cao, H.L. Sun*, and Z.Y. Zhong*, Immuno-nanoinhibitor potentiates molecular targeted therapy of T-cell acute lymphoblastic leukemia. Sci. China Technol. Sci. 2026, 69, 1720201.295.pdf

294. X.F. Zhao, Q.Z. Ren, X. Wang, S.Y. Wang, C.C. Xu, Z.Y. Zhong*, and C. Deng*, Membrane-fusogenic polyamidoamines mediate ultralow-dose mRNA transfection through direct cytosolic delivery. Mater. Today. 2026, 97, 103352.294.pdf

293. X. Wang, X.F. Zhao, F. Zhang, S.Y. Wang, F.H. Meng, C. Deng*, M.Z. Ye*, and Z.Y. Zhong*, ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia. Sci. Adv. 2026, accepted.293.pdf

292. S.J. Yue, Z.Z. Zhai, J.N. An, H.L. Sun*, J.Y. Li, C.Z. Zhao, Y. Xu*, Z.Y. Zhong*, Neutrophil/Leukemia-Tropic Dual-Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia, Adv. Mater. 2026, 38, 2512635.  292.pdf

291. J.K. Guo, J.T. Huang, Z.L. Huang, J. Sun, Y. Wang, H.J. Tan, D. Hu, C. Deng*, X.L. Zhu*, Z.Y. Zhong*, Persistent and Potent Anticancer Immunity Empowered by Manganese-Coordinated STING-Activating Microgels, Adv. Funct. Mater. 2026, 36, e21279. 291.pdf

290. Y. Wang, J.K. Guo, D. Hu, H.J. Tan, W.T. Chen, C. Deng*, X.L. Zhu*, Z.Y. Zhong*, Absorbable microspheres sustaining epirubicin and TLR7 agonist release for transarterial chemo-immuno-embolization in liver tumor, J. Control. Release 2026, 390, 114576.290.pdf

289. F.H. Meng, S.P.  Schwendeman, A. Pego, Z.Y. Zhong*, Celebrating the 80th birthday of professor Jan Feijen, J. Control. Release 2026, 391, 114618.289.pdf

288. C.L. Ye, Y. Zheng, H.L. He, J.L. Ji, L. Liu, Y. Sun, Y.W. Peng, S.Q. Wang, Y. Zhang*,  Z.Y. Zhong*, Single-fraction radiotherapy with a bioactive depot of CD39 blockade eradicates malignant tumors, J. Control. Release 2026, 391, 1145632.288.pdf

287. X.S. Zhang, G. Cai, S.S. Zhao, Y.Y. Qu, R.K. Lv, Y.J. Sha, L.Y. Zhu, Z.Y. Zhong*, F.H. Meng*, A locoregional program of photothermal debulking, stemness suppression, and dendritic cell activation for durable glioblastoma immunotherapy. J. Control. Release. 2026,396:115089.287.pdf

286. Y. Zheng, H. L. He, Y. W. Peng, C. L. Ye, J. L. Ji, X. T. Kong,Y. Zhang*, Z.Y. Zhong*, Multi-immunogenic bioadhesive chitosan-lecithin-podophyllotoxin nanoparticles elicit robust systemic anticancer immunity. Sci. China Mater. 2026, doi: 10.1007/s40843-026-4152-4.286.pdf

285. L.Y. Zhu, Y.J. Sha, X.S. Zhang, Y.Y. Qu, Z.Y. Zhong, S.Y. Miao, G. Cai, F.H. Meng*, Macrophage-hitchhiking nanomedicine codelivering gemcitabine and KRAS G12D inhibitor orchestrates chemo-immunotherapy for metastatic colorectal cancer. J. Control. Release 2026, 396,115045.285.pdf

284. L.L. Yao; S.X. Li; X.H. Zhang; Y.K. Zhai; J.P. Shen; C. Deng; W.H. Lin*; S.L. Li*; Z.Y. Zhong*, STING Activation by Photo-immunogenic Nanophotocages for Synergistic Photoimmunotherapy of Cold Tumor, J. Am. Chem. Soc. 2026, 148 (28): 29710–29722.284.pdf

283. Q. Z. Ren, X.F. Zhao, L.L. Zhou, R.N. Ye, L.G. Chen, K.Y. Ren, X.J. Piao, Y. H. Zhou, Y.M. Qi, K.C. Chan, L. Cao, L. Du, P. Gao, B. Ying, C. Deng, F. H. Meng, F. F. Zhou*, C. C. Xu*, and Z. Y. Zhong*, Polymer-mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination, Nat. Biomed. Eng. 2026, doi: 10.1038/s41551-026-01672-0. 283.pdf

282. Z.L. Huang, Y. Wang, J.K. Guo, S.H. Lv, J. Gui, Z.Y. Zhong*, J. Chen*, and C. Deng*, Broad-spectrum insecticide detoxification for the protection of managed pollinators, Nature Sustainability. Nat. Sustain. 2026, doi: 10.1038/s41893-026-01867-y.282.pdf